12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks showed notable movements. Apollomics, Cara Therapeutics, Coeptis Therapeutics, Titan Pharma, BioSig Technologies, and Iridex were among the gainers, with increases ranging from 5.52% to 10.9%. On the downside, Akili, Mira Pharmaceuticals, Estrella Immunopharma, Virpax Pharmaceuticals, United Therapeutics, and ProSomnus experienced declines between 6.46% and 22.9%. Iridex and ProSomnus also released their Q4 earnings.
March 26, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akili stock decreased by 22.9% to $0.29, with a market cap of $23.0 million.
The significant drop in Akili's stock price could indicate negative investor sentiment, likely leading to short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
ProSomnus stock decreased by 6.46% to $0.58, with a market value of $10.0 million. Q4 earnings were announced.
The decline in stock price post-Q4 earnings announcement could reflect a negative market reaction to the financial results, suggesting short-term bearish sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 95
POSITIVE IMPACT
Apollomics stock rose 10.9% to $0.61, with a market value of $54.5 million.
The significant after-market gain suggests positive investor sentiment, potentially leading to short-term upward price momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Cara Therapeutics shares increased by 7.36% to $0.78, with a market cap of $42.8 million.
The rise in Cara Therapeutics' stock price indicates a positive market reaction, likely contributing to short-term bullish behavior.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Iridex stock increased by 5.52% to $2.65, with a market cap of $43.0 million. Q4 earnings were released.
The increase in stock price following the Q4 earnings release suggests a positive market response to the financial results, indicating potential short-term growth.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 95